Schreiner MediPharm, a specialist in functional labels for the healthcare sector, has introduced an innovative cut-through indicator function for pharmaceutical closure seals. This advanced feature reveals tampering attempts, such as cutting and resealing, making such actions clearly visible and irreversible.
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industries, has unveiled a brand unification strategy, consolidating its worldwide operations under a single name. The initiative merges the capabilities of
Viva Biotech Holdings Group has announced the establishment of a new branch in Boston, Massachusetts, as part of its globalisation strategy. The company, renowned for its comprehensive drug research, development, and manufacturing services, will leverage Boston’s robust biopharma ecosystem to
NorthStar Medical Radioisotopes, LLC, a leader in radiopharmaceuticals, has signed a supply agreement with Ariceum Therapeutics, a biotech company specialising in radiopharmaceutical cancer treatments. The agreement ensures Ariceum receives non-carrier-added, high-purity Actinium-225 (Ac-225), a critical isotope for advancing its therapeutic
Benuvia Operations, LLC, a global CDMO, has announced a licensing partnership with Avernus Pharma, granting Avernus exclusive distribution rights for SYNDROS in the Gulf Cooperation Council (GCC) region. This encompasses Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE, pending
Cellipont Bioservices, a cell therapy-focused Contract Development and Manufacturing Organization (CDMO), has announced a strategic partnership with Xiogenix, a biopharmaceutical technology innovator. The partnership introduces the advanced Ares X20 fill-and-finish system to Cellipont’s manufacturing capabilities, enabling more precise and efficient
Phastar, a global biometrics contract research organisation (CRO), has been named the Best CRO – Specialist Providers at the 2024 Scrip Awards. The award ceremony took place on December 4th at Raffles London at the OWO, celebrating the company’s specialised
Ascendia Pharmaceuticals, a contract development and manufacturing organisation (CDMO), has officially rebranded as Ascendia Pharmaceutical Solutions. The new identity underscores the company’s evolution and its commitment to offering comprehensive drug development services to its biopharma clients. Founded 13 years ago
Tower Cold Chain, a provider of passive temperature-controlled containers, has solidified its global position following its acquisition by Cold Chain Technologies (CCT). This strategic move enhances both companies’ capabilities, expanding their reach and offering a comprehensive suite of solutions for
Hanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.” Founded in
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
